Skip to main content

Advertisement

SpringerLink
Log in

Oxidatively Modified GST and MRP1 in Alzheimer’s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Alzheimer disease (AD) is a neurodegenerative disorder characterized pathologically by intracellular inclusions including neurofibrillary tangles (NFT) and senile plaques. Several lines of evidence implicate oxidative stress with the progression of AD. 4-hydroxy-2-trans-nonenal (HNE), an aldehydic product of membrane lipid peroxidation, is increased in AD brain. The alpha class of glutathione S-transferase (GST) can detoxify HNE and plays an important role in cellular protection against oxidative stress. The export of the glutathione conjugate of HNE is required to fully potentiate the GST-mediated protection. The multidrug resistance protein-1 (MRP1) and GST proteins may act in synergy to confer cellular protection. In the present study, we studied oxidative modification of GST and MRP1 in AD brain by immunoprecipitation of GST and MRP1 proteins followed by Western blot analysis using anti-HNE antibody. The results suggested that HNE is covalently bound to GST and MRP1 proteins in excess in AD brain. Collectively, the data suggest that HNE may be an important mediator of oxidative stress-induced impairment of this detoxifying system and may thereby play a role in promoting neuronal cell death. The results from this study also imply that augmenting endogenous oxidative defense capacity through dietary or pharmacological intake of antioxidants may slow down the progression of neurodegenerative processes in AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • R. Katzman T. Saitoh (1991) ArticleTitleAdvances in Alzheimer’s disease FASEB J. 5 278–286

    Google Scholar 

  • E. Masliah (1998) ArticleTitleMechanisms of synaptic pathology in Alzheimer’s disease J. Neural Transm. 53 147–158

    Google Scholar 

  • S. Sinha I. Lieberburg (1999) ArticleTitleCellular mechanisms of beta-amyloid production and secretion Proc. Natl. Acad. Sci. USA 96 11049–11053

    Google Scholar 

  • D. A. Butterfield A. Castegna C. M. Lauderback J. Drake (2002) ArticleTitleEvidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death Neurobiol. Aging 23 655–664

    Google Scholar 

  • W. R. Markesbery J. H. Carney (1999) ArticleTitleOxidative alterations in Alzheimer’s disease Brain Pathol. 9 133–146

    Google Scholar 

  • D. A. Butterfield D. A. Lauderback (2002) ArticleTitleLipid peroxidation and protein oxidation in Alzheimer’s disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radic. Biol. Med. 32 1050–1060

    Google Scholar 

  • W. R. Markesbery M. A Lovell (1998) ArticleTitleFour-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease Neurobiol. Aging. 19 33–36

    Google Scholar 

  • M. J. Picklo J. Montine V. Amarnath M. D. Neely (2002) ArticleTitleCarbonyl toxicology and Alzheimer’s disease. Toxicol. Appl. Pharmacol 184 187–197

    Google Scholar 

  • M. A. Lovell C. Xie W. R. Markesbery (2000) ArticleTitleAcrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures Free Radic. Biol. Med. 29 714–720

    Google Scholar 

  • L. T. McGrath B. M. McGleenon S. Brennan McColl S. McILroy A. P. Passmore (2001) ArticleTitleIncreased oxidative stress in Alzheimer’s disease as assessed with 4-hydroxynonenal but not malondialdehyde QJM. 94 485–490

    Google Scholar 

  • M. A. Lovell W. D. Ehmann M. P. Mattson W. R. Markesbery (1997) ArticleTitleElevated 4-hydroxynonenal in ventricular fluid in Alzheimer’s disease Neurobiol. Aging 18 457–61

    Google Scholar 

  • P. Alin U. H. Danielson B. Mannervik (1985) ArticleTitle4-Hydroxyalk-2-enals are substrates for glutathione transferase FEBS Lett. 179 267–270

    Google Scholar 

  • M. A. Lovell C. Xie W. R. Markesbery (1998) ArticleTitleDecreased glutathione transferase activity in brain and ventricular fluid in Alzheimer’s disease Neurology. 51 1562–1566

    Google Scholar 

  • B. Mannervik U. H. Danielson (1988) ArticleTitleGlutathione transferases—structure and catalytic activity Crit. Rev. Biochem. 23 283–337

    Google Scholar 

  • Y. Yang R. Sharma P. Zimniak Y.C. Awasthi (2002) ArticleTitleRole of alpha class glutathione S-transferases as antioxidant enzymes in rodent tissues Toxicol. Appl. Pharmacol. 182 105–115

    Google Scholar 

  • J. D. Hayes R. C. Strange (1995) ArticleTitlePotential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress Free Radic Res. 22 193–207

    Google Scholar 

  • C. S. Morrow P. K. Smitherman S. K. Diah E. Schneider A. J. Townsend (1998) ArticleTitleCoordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. J. Biol. Chem. 273 20114–20120

    Google Scholar 

  • M. O. Pinkett W. B. Anderson (1980) ArticleTitleAlterations in plasma membrane proteins associated with the proteolytic activation of adenylate cyclase Arch. Biochem. Biophys. 200 261–268

    Google Scholar 

  • W. H. Habig W. B. Jakoby (1981) ArticleTitleAssays for differentiation of glutathione S-transferases Methods Enzymol. 77 398–405

    Google Scholar 

  • T. J. Montine M. D. Neely J. F. Quinn M. F. Beal W. R. Markesbery L. J. Roberts J. D. Morrow (2002) ArticleTitleLipid peroxidation in aging brain and Alzheimer’s disease Free Radic. Biol. Med. 33 620–626

    Google Scholar 

  • D. Pratico V. M. Lee J. Q. Trojanowski J. Rokach G. A. Fitzgerald (1998) ArticleTitleIncreased F2-isoprostanes in Alzheimer’s disease: evidence for enhanced lipid peroxidation in vivo FASEB J. 12 1777–1784

    Google Scholar 

  • K. Zarkovic (2003) ArticleTitle4-hydroxynonenal and neurodegenerative diseases Mol. Aspects Med. 24 293–303

    Google Scholar 

  • K. Uchida S. Toyokuni K. Nishikawa S. Kawakishi H. Oda H. Hiai E. R. Stadtman (1994) ArticleTitleMichael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: Markers for atherosclerosis Biochemistry 33 12487–12494

    Google Scholar 

  • R. J. Mark M. A. Lovell W. R. Markesbery K. Uchida M. P. Mattson (1997) ArticleTitleA role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal cell death induced by amyloid β-peptide J. Neurochem. 68 255–264

    Google Scholar 

  • J. N. Keller R. J. Mark A. J. Bruce E. Blanc J. D. Rothstein K. Uchida G. Waeg M. P. Mattson (1997) ArticleTitle4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes Neuroscience 80 685–696

    Google Scholar 

  • R. J. Mark Z. Pang J. W. Geddes K. Uchida M. P. Mattson (1997) ArticleTitleAmyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation J. Neurosci. 17 1046–1054

    Google Scholar 

  • E. M. Blanc J. F. Kelly R. J. Mark G. Waeg M. P. Mattson (1997) ArticleTitle4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: Possible action on G alpha(q/11) J. Neurochem. 69 570–580

    Google Scholar 

  • J. N. Keller K. B. Hanni W. R. Markesbery (2000) ArticleTitleImpaired proteasome function in Alzheimer’s disease J. Neurochem. 75 436–439

    Google Scholar 

  • C. Xie M. A. Lovell S. Xiong M. S. Kindy J. Guo J. Xie V. Amaranth T. J. Montine W. R. Markesbery (2001) ArticleTitleExpression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress Free Radic. Biol. Med. 31 73–81

    Google Scholar 

  • L. Homolya A. Varadi B. Sarkadi (2003) ArticleTitleMultidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate Biofactors 17 103–114

    Google Scholar 

  • D. W. Loe K. C. Almquist R. G. Deeley S. P. Cole (1996) ArticleTitleMultidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles Demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271 9675–9682

    Google Scholar 

  • R. Subramaniam F. Roediger B. Jordan M. P. Mattson J. N. Keller G. Waeg D. A. Butterfield (1997) ArticleTitleThe lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins J. Neurochem. 69 1161–1169

    Google Scholar 

  • M. Aksenov M. Aksenova D. A. Butterfield W. R. Markesbery (2000) ArticleTitleOxidative modification of creatine kinase BB in Alzheimer’s disease brain J. Neurochem. 74 2520–2527

    Google Scholar 

  • A. Castegna M. Aksenov M. Aksenova V. Thongboonkerd J. B. Klein W. M. Pierce R. Booze W. R. Markesbery D. A. Butterfield (2002) ArticleTitleProteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33 562–571

    Google Scholar 

  • C. M. Lauderback J. M. Hackett F. F. Huang J. N. Keller L. I. Szweda W. R Markesbery D. A. Butterfield (2001) ArticleTitleThe glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer’s disease brain: The role of Abeta1-42 J. Neurochem. 78 413–416

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, University of Kentucky, Lexington, KY, 40506, USA

    Rukhsana Sultana & D. Allan Butterfield

  2. Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, 40506, USA

    D. Allan Butterfield

  3. Center of Membrane Sciences, University of Kentucky, Lexington, KY, 40506, USA

    Rukhsana Sultana & D. Allan Butterfield

  4. Department of Chemistry, Center of Membrane Sciences, and Sanders-Brown Center on Aging , University of Kentucky, Lexington, KY, 40506, USA

    D. Allan Butterfield

Authors
  1. Rukhsana Sultana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Allan Butterfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Allan Butterfield.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sultana, R., Butterfield, D.A. Oxidatively Modified GST and MRP1 in Alzheimer’s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products. Neurochem Res 29, 2215–2220 (2004). https://doi.org/10.1007/s11064-004-7028-0

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-004-7028-0

Keywords

Search

Navigation